RCS officials endorse transferring $1 million from health reserve to cover rising prescription costs

The Ravena-Coeymans-Selkirk Central School District indicated support Tuesday for a staff recommendation to transfer $1,000,000 from the district's health-insurance reserve to its prescription-drug reserve to cover an ongoing shortfall.

District staff said the prescription account, which the district administers separately inside a consortium, has been running a monthly deficit and had dropped to about $115,000 as of April. “Our expenses are almost double what we're bringing in,” the staff member presenting the financial update said, noting that specialty drugs — including weight-loss medications — are a major driver of increased pharmacy claims.

The recommendation came from the health consortium trustee who presented the reserve summary to the board. The trustee said the consortium recommends roughly two months of health reserves and about four months for prescription reserves. The district’s health reserve is about $4 million, above the consortium’s suggested level of roughly $1.4 million. Staff advised moving $1 million to the Rx account as an interim measure.

Why it matters: board members and staff said an infusion to the Rx reserve will slow the pace at which unusually large monthly claims erode the district’s prescription fund balance and reduce the urgency of near-term premium increases. The presenter told the board that prescription premiums for next year are already set to rise by about 20 percent and that consortium-level work is underway to manage exceptional claim drivers across member districts.

Details from the discussion: Jesse, the staff member who presented the benefits report, described how the district participates in a regional consortium for health plans but is effectively “on our own” for prescription coverage because Rx claims are treated at the district level. He told the board the consortium advised moving $1 million and that he did not require a formal motion to act, but wanted the board’s input. Multiple board members responded that they were comfortable with the plan; one member noted concern about moving “too much” out of the health reserve because higher fund balances can help blunt future rate increases.

Implementation and next steps: Jesse said he would notify the consortium trustee to make the transfer. He also said the consortium is working on longer-term measures to control Rx costs, including contractual changes to rebating and utilization rules.

What was not decided: there was no formal roll-call vote recorded in the meeting minutes; the transcript records board members expressing assent (for example: “I’m good with that”) and the presenter saying he planned to proceed with the recommended transfer.

Board context: the board asked clarifying questions about how the reserves are calculated, whether the $4 million figure is the district’s portion of the consortium reserve, and whether shifting funds would affect future rate-setting. Presenting staff explained the $4 million is the district’s portion and that the consortium has a plan to make use of bigger balances across members to limit future premium pressure.

The board asked staff to provide more detailed historical claims and rebate data at a future meeting so members could evaluate whether additional transfers or other budget adjustments are needed.